Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Health's Oncotype DX Test Meets Blue Cross and Blue Shield Standards

NEW YORK (GenomeWeb News) — A Blue Cross and Blue Shield Medical Advisory Panel has decided that Genomic Health’s Oncotype DX assay meets criteria set by the insurance company’s Technology Evaluation Center as a diagnostic for certain breast cancers, Genomic Health said today.
 
At a meeting last month the advisory panel concluded that the test meets its criteria for women with estrogen receptor-positive, node-negative, tamoxifen-treated breast cancer, Genomic Health said.
 
The assessment, which is for "informational purposes only," does not guarantee that Blue Cross and Blue Shield payor companies will cover the test, according to a Blue Cross and Blue Shield official. Blue Cross and Blue Shield payor companies make their own decisions about what they will cover, but may take a scientific assessment into account as they decide what to cover, the official said.
 
The company said the test has clinical evidence of its ability “to predict the likelihood of breast cancer recurrence, the likelihood of patient survival within 10 years of diagnosis and the likelihood of chemotherapy benefit.”

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.